SEAMLESS

Chemicals for use in industry and science; biological preparations for use in industry and science, biological reagents, for use in industry and science, not for medical purposes

Pharmaceutical and biological preparations and, gene therapies and gene-editing therapies, all for the treatment of genetic and viral diseases; medical, pharmaceutical and biopharmaceutical preparations and programmable recombinases substances for the treatment of genetic and viral diseases; pharmaceutical goods and preparations, namely, gene transfer, regulation, modulation and delivery medications for the treatment of genetic and viral diseases and disorders; products, agents, for medical purposes, for veterinary purposes in the nature of gene and gene editing therapies; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymes, especially, recombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymes, in particular recombinases and integrases, for the treatment of diseases being enzymes for medical purposes

Scientific and technological services and research, especially creation of bioinformatic algorithms and models; science and technology services in the nature of gene therapies, scientific and technological research in the nature of gene editing technology, scientific development services, technological development, in the fields of gene, genome and cell editing, genome modulation, genome modification, engineering, gene regulation, repair and therapy and for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; consultancy services relating to development of pharmaceutical and biological preparations or medications for humans in the field of gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy; genome engineering services; scientific research relating to genetics, and scientific research, in the field of genome editing; analytical scientific laboratory services; medical research laboratory services; scientific laboratory services; gene therapy research laboratories; scientific research and development; development of pharmaceutical preparations and medicines; pharmaceutical products development; bioinformatic research for identification of target sequences for genome editing in a cell's DNA; scientific research in the nature of bioinformatic research for identification of target sequences for genome editing in a cell's DNA by genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; scientific research in the nature of bioinformatic or computational analysis to identify target sequences in a cell's DNA; screening processes, in silico DNA screening using bioinformatics and computational approaches and DNA high-throughput screening, for the identification of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases, all for scientific research purposes; scientific research and development for the pharmaceutical industry; technological consultancy in the field of diseases by means of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases

Medical services; medical analysis relating to the treatment of persons; Gene and genome assay services, for treatment purposes; medical services and medical services, in relation to the fields of genome editing; genetic counseling; gene therapy services; Medical services, namely services for the preparation of medical reports; medical services, namely, providing personalised healthcare and medical information; medical services, namely, providing gene therapy recommendations; providing of medical information and medical counselling services in relation to the fields of medical services, health care services; medical therapy consultancy, in relation to the fields of genome editing; medical counselling relating to recombinases and integrases for the treatment of diseases